Rita Hutyra-gram

Publications
Public outreach and news

Articles

Article: BMC CANCER. 2011;11:441
Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines
Otvos R; Skribek H; Kis LL; Gloghini A; Markasz L; Flaberg E; Eksborg S; Konya J; Gergely L; Carbone A; Szekely L
Article: EXPERIMENTAL HEMATOLOGY. 2010;38(12):1219-1230
Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin
Skribek H; Otvos R; Flaberg E; Nagy N; Markasz L; Eksborg S; Masszi T; Kozma A; Adam E; Miseta A; Klein E; Szekely L
Article: BIOMEDICINE & PHARMACOTHERAPY. 2009;63(6):413-420
NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab
Markasz L; Vanherberghen B; Flaberg E; Otvos R; Stuber G; Jernberg AG; Olah E; Skribek H; Szekely L
Article: MOLECULAR CANCER. 2009;8:23
PRIMA-1^MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein
Stuber G; Flaberg E; Petranyi G; Otvos R; Rokaeus N; Kashuba E; Wiman KG; Klein G; Szekely L
Article: JOURNAL OF IMMUNOTHERAPY. 2008;31(3):283-293
Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes
Markasz L; Skribek H; Uhlin M; Otvos R; Flaberg E; Eksborg S; Olah E; Stuber G; Szekely L
Article: LEUKEMIA AND LYMPHOMA. 2007;48(9):1835-1845
Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel
Markasz L; Kis LL; Stuber G; Flaberg E; Otvos R; Eksborg S; Skribek H; Olah E; Szekely L

Articles

News from KI

Events from KI